The transcriptome of GBM patient tissue (TCGA) as well as patient derived cell lines (HGCC) under various molecularly distinct subtypes (classical, mesenchymal, neural and proneural) showed enhanced SUMO2 expression (Fig. 2G, H and Additional file 4: Table S29, 30). The gene discussed is SUMO2; the disease is glioblastoma.